Liver Transplantation for Transthyretin Amyloidosis View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2009-07-29

AUTHORS

Bo-Göran Ericzon , Erik Lundgren , Ole B. Suhr

ABSTRACT

Liver transplantation has until now proved to be the only treatment available that halts the progression of hereditary transthyretin (TTR) associated amyloidosis. The rationale behind the procedure is to replace the liver producing variant TTR with one that produces wild type TTR only, and thereby cease the production of amyloidogenic TTR (ATTR). Even though the transplantation does not improve the patient's symptoms, the progression of the disease comes to a halt for a majority of patients. However, unforeseen complications after the transplantation have emerged, in particular a continuous amyloid formation in the heart observed in non-ATTR Val30Met mutations. Thus, combined liver and heart transplantation has been performed in selected cases.Since the ATTR liver functions normally apart from a synthesis of the variant TTR, utilisation of ATTR-amyloid patients' livers for transplantation of liver disease patients has been performed. In a few patients, development of amyloid disease has been reported, but the procedure remains an important source of organs, especially for patients with hepatocellular cancer. More... »

PAGES

239-260

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-00646-3_15

DOI

http://dx.doi.org/10.1007/978-3-642-00646-3_15

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009502106


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Head Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital Huddinge, F82, 141 86, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Head Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital Huddinge, F82, 141 86, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ericzon", 
        "givenName": "Bo-G\u00f6ran", 
        "id": "sg:person.01041170032.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041170032.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Biology, Ume\u00e5 University, 901 87, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Department of Molecular Biology, Ume\u00e5 University, 901 87, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lundgren", 
        "givenName": "Erik", 
        "id": "sg:person.0713005341.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713005341.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Section for Gastroenterology and Hepatology, Ume\u00e5 University Hospital, 901 85, Ume\u00e5, SE, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.412215.1", 
          "name": [
            "Department of Medicine, Section for Gastroenterology and Hepatology, Ume\u00e5 University Hospital, 901 85, Ume\u00e5, SE, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suhr", 
        "givenName": "Ole B.", 
        "id": "sg:person.01002240562.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002240562.00"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2009-07-29", 
    "datePublishedReg": "2009-07-29", 
    "description": "Liver transplantation has until now proved to be the only treatment available that halts the progression of hereditary transthyretin (TTR) associated amyloidosis. The rationale behind the procedure is to replace the liver producing variant TTR with one that produces wild type TTR only, and thereby cease the production of amyloidogenic TTR (ATTR). Even though the transplantation does not improve the patient's symptoms, the progression of the disease comes to a halt for a majority of patients. However, unforeseen complications after the transplantation have emerged, in particular a continuous amyloid formation in the heart observed in non-ATTR Val30Met mutations. Thus, combined liver and heart transplantation has been performed in selected cases.Since the ATTR liver functions normally apart from a synthesis of the variant TTR, utilisation of ATTR-amyloid patients' livers for transplantation of liver disease patients has been performed. In a few patients, development of amyloid disease has been reported, but the procedure remains an important source of organs, especially for patients with hepatocellular cancer.", 
    "editor": [
      {
        "familyName": "Richardson", 
        "givenName": "Samantha J.", 
        "type": "Person"
      }, 
      {
        "familyName": "Cody", 
        "givenName": "Vivian", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-00646-3_15", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-00645-6", 
        "978-3-642-00646-3"
      ], 
      "name": "Recent Advances in Transthyretin Evolution, Structure and Biological Functions", 
      "type": "Book"
    }, 
    "keywords": [
      "liver transplantation", 
      "variant transthyretin", 
      "liver disease patients", 
      "majority of patients", 
      "heart transplantation", 
      "patient's symptoms", 
      "liver function", 
      "disease patients", 
      "hepatocellular cancer", 
      "transplantation", 
      "Val30Met mutation", 
      "transthyretin amyloidosis", 
      "patients", 
      "patient's liver", 
      "only treatment", 
      "hereditary transthyretin", 
      "unforeseen complications", 
      "liver", 
      "symptoms", 
      "amyloidosis", 
      "wild-type transthyretin", 
      "disease", 
      "amyloidogenic transthyretin", 
      "transthyretin", 
      "progression", 
      "amyloidogenic TTR", 
      "complications", 
      "amyloid diseases", 
      "cancer", 
      "amyloid formation", 
      "treatment", 
      "heart", 
      "organs", 
      "procedure", 
      "majority", 
      "mutations", 
      "rationale", 
      "cases", 
      "important source", 
      "function", 
      "utilisation", 
      "development", 
      "production", 
      "formation", 
      "synthesis", 
      "halt", 
      "source"
    ], 
    "name": "Liver Transplantation for Transthyretin Amyloidosis", 
    "pagination": "239-260", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009502106"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-00646-3_15"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-00646-3_15", 
      "https://app.dimensions.ai/details/publication/pub.1009502106"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_202.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-642-00646-3_15"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-00646-3_15'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-00646-3_15'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-00646-3_15'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-00646-3_15'


 

This table displays all metadata directly associated to this object as RDF triples.

131 TRIPLES      22 PREDICATES      71 URIs      64 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-00646-3_15 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N5059da33e5b943da9f1a58db8a2da69e
4 schema:datePublished 2009-07-29
5 schema:datePublishedReg 2009-07-29
6 schema:description Liver transplantation has until now proved to be the only treatment available that halts the progression of hereditary transthyretin (TTR) associated amyloidosis. The rationale behind the procedure is to replace the liver producing variant TTR with one that produces wild type TTR only, and thereby cease the production of amyloidogenic TTR (ATTR). Even though the transplantation does not improve the patient's symptoms, the progression of the disease comes to a halt for a majority of patients. However, unforeseen complications after the transplantation have emerged, in particular a continuous amyloid formation in the heart observed in non-ATTR Val30Met mutations. Thus, combined liver and heart transplantation has been performed in selected cases.Since the ATTR liver functions normally apart from a synthesis of the variant TTR, utilisation of ATTR-amyloid patients' livers for transplantation of liver disease patients has been performed. In a few patients, development of amyloid disease has been reported, but the procedure remains an important source of organs, especially for patients with hepatocellular cancer.
7 schema:editor N289253f26bd741b1a42c1e229e484cb8
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Nf209359ffa9541d18c6ac775aab7d782
11 schema:keywords Val30Met mutation
12 amyloid diseases
13 amyloid formation
14 amyloidogenic TTR
15 amyloidogenic transthyretin
16 amyloidosis
17 cancer
18 cases
19 complications
20 development
21 disease
22 disease patients
23 formation
24 function
25 halt
26 heart
27 heart transplantation
28 hepatocellular cancer
29 hereditary transthyretin
30 important source
31 liver
32 liver disease patients
33 liver function
34 liver transplantation
35 majority
36 majority of patients
37 mutations
38 only treatment
39 organs
40 patient's liver
41 patient's symptoms
42 patients
43 procedure
44 production
45 progression
46 rationale
47 source
48 symptoms
49 synthesis
50 transplantation
51 transthyretin
52 transthyretin amyloidosis
53 treatment
54 unforeseen complications
55 utilisation
56 variant transthyretin
57 wild-type transthyretin
58 schema:name Liver Transplantation for Transthyretin Amyloidosis
59 schema:pagination 239-260
60 schema:productId N7e01ab66ead245efa74c5102490e8474
61 Nf06de7333a5943908a23865cc2c00a6c
62 schema:publisher N74e632ef61b5497d8d3576508be65410
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009502106
64 https://doi.org/10.1007/978-3-642-00646-3_15
65 schema:sdDatePublished 2022-09-02T16:11
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Na150340c77b14ff2a58a30f1d0649e36
68 schema:url https://doi.org/10.1007/978-3-642-00646-3_15
69 sgo:license sg:explorer/license/
70 sgo:sdDataset chapters
71 rdf:type schema:Chapter
72 N0e98127d7fb94b9ba898f1d9ac8e99b3 schema:familyName Cody
73 schema:givenName Vivian
74 rdf:type schema:Person
75 N289253f26bd741b1a42c1e229e484cb8 rdf:first N78298adc5849402f8e297d4cb2bde141
76 rdf:rest Nda768fbeb2944a3f889980dfeb9c5224
77 N5059da33e5b943da9f1a58db8a2da69e rdf:first sg:person.01041170032.09
78 rdf:rest Naaac099312584c8d91770aa3cc7c3b13
79 N74e632ef61b5497d8d3576508be65410 schema:name Springer Nature
80 rdf:type schema:Organisation
81 N78298adc5849402f8e297d4cb2bde141 schema:familyName Richardson
82 schema:givenName Samantha J.
83 rdf:type schema:Person
84 N7e01ab66ead245efa74c5102490e8474 schema:name dimensions_id
85 schema:value pub.1009502106
86 rdf:type schema:PropertyValue
87 Na150340c77b14ff2a58a30f1d0649e36 schema:name Springer Nature - SN SciGraph project
88 rdf:type schema:Organization
89 Naaac099312584c8d91770aa3cc7c3b13 rdf:first sg:person.0713005341.81
90 rdf:rest Nd94b6fb24bb94959a07e5bc848933835
91 Nd94b6fb24bb94959a07e5bc848933835 rdf:first sg:person.01002240562.00
92 rdf:rest rdf:nil
93 Nda768fbeb2944a3f889980dfeb9c5224 rdf:first N0e98127d7fb94b9ba898f1d9ac8e99b3
94 rdf:rest rdf:nil
95 Nf06de7333a5943908a23865cc2c00a6c schema:name doi
96 schema:value 10.1007/978-3-642-00646-3_15
97 rdf:type schema:PropertyValue
98 Nf209359ffa9541d18c6ac775aab7d782 schema:isbn 978-3-642-00645-6
99 978-3-642-00646-3
100 schema:name Recent Advances in Transthyretin Evolution, Structure and Biological Functions
101 rdf:type schema:Book
102 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
103 schema:name Medical and Health Sciences
104 rdf:type schema:DefinedTerm
105 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
106 schema:name Cardiorespiratory Medicine and Haematology
107 rdf:type schema:DefinedTerm
108 sg:person.01002240562.00 schema:affiliation grid-institutes:grid.412215.1
109 schema:familyName Suhr
110 schema:givenName Ole B.
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002240562.00
112 rdf:type schema:Person
113 sg:person.01041170032.09 schema:affiliation grid-institutes:grid.4714.6
114 schema:familyName Ericzon
115 schema:givenName Bo-Göran
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041170032.09
117 rdf:type schema:Person
118 sg:person.0713005341.81 schema:affiliation grid-institutes:grid.12650.30
119 schema:familyName Lundgren
120 schema:givenName Erik
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713005341.81
122 rdf:type schema:Person
123 grid-institutes:grid.12650.30 schema:alternateName Department of Molecular Biology, Umeå University, 901 87, Umeå, Sweden
124 schema:name Department of Molecular Biology, Umeå University, 901 87, Umeå, Sweden
125 rdf:type schema:Organization
126 grid-institutes:grid.412215.1 schema:alternateName Department of Medicine, Section for Gastroenterology and Hepatology, Umeå University Hospital, 901 85, Umeå, SE, Sweden
127 schema:name Department of Medicine, Section for Gastroenterology and Hepatology, Umeå University Hospital, 901 85, Umeå, SE, Sweden
128 rdf:type schema:Organization
129 grid-institutes:grid.4714.6 schema:alternateName Head Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital Huddinge, F82, 141 86, Stockholm, Sweden
130 schema:name Head Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital Huddinge, F82, 141 86, Stockholm, Sweden
131 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...